Revision history of "DEVELOPMENT OF A MONOCLONAL ANTIBODY AS A THERAPEUTIC TREATMENT IN THE AREA OF INFECTIOUS DISEASES (DAMCLUAB)" (Q2024121)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 October 2024

  • curprev 16:2016:20, 7 October 2024DG Regio talk contribs 59,543 bytes −3 Changed label, description and/or aliases in pt
  • curprev 16:2016:20, 7 October 2024DG Regio talk contribs 59,546 bytes +47 Set a claim value: summary (P836): * um indivíduo * ediante la TECNOLOGY FOR hybridoma E ha DIMSTRATO EFICCIA bloqueando A PROLIFERAÇÃO DE OPERADORES FUNGHI. PARA INDUSTRIALIZAR O PRODUTO, O PRESENTE PROJECTO AUMENTA UM NÚMERO DE OBJECTIVOS E ACTIVIDADES: 1) GERAÇÃO DE UMA LINHA DE CELULOSE PARA PRODUÇÃO INDUSTRIAL À ESCALA, 2) PRODUÇÃO DE UM LOTE DE ANTIBOLOGIA DE GRANDES ESCALAS, 3) ESTUDO DE EFICIÊNCIA DO ANTIBOLOGIA MONOCLONAL COM UM MODELO DE ASPERGILOSE INVASIVA EM RODENTES. A...

20 March 2024

14 June 2023

12 June 2023

26 April 2023

8 April 2023

5 July 2022

  • curprev 01:2501:25, 5 July 2022DG Regio talk contribs 56,893 bytes +37,732 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et,

10 February 2022

24 January 2022

24 December 2021

23 December 2021

14 December 2021

2 November 2020

15 July 2020

8 June 2020

24 March 2020

23 March 2020

  • curprev 18:1018:10, 23 March 2020DG Regio talk contribs 9,755 bytes +1,273 Created claim: summary (P836): * an individual * ediante la TECNOLOGY FOR hybridoma E ha DIMSTRATO EFICCIA blocking THE PROLIFERATION OF FUNGHI OPERATORS. IN ORDER TO INDUSTRIALISE THE PRODUCT, THIS PROJECT RAISES A NUMBER OF OBJECTIVES AND ACTIVITIES: 1) GENERATION OF A CELL LINE FOR INDUSTRIAL SCALE PRODUCTION, (2) PRODUCTION OF A LARGE-SCALE ANTIBODY BATCH, (3) EFFICACY STUDY OF THE MONOCLONAL ANTIBODY IN A MODEL OF INVASIVE ASPERGILLOSIS IN RODENTS. THE CREATION OF A BUSI...

20 March 2020

18 March 2020

12 March 2020

6 March 2020